Rheumatic manifestations in HIV-infected patients

被引:0
作者
Galanopoulos, N. [1 ]
Papatheodorou, K. [2 ]
Maltezos, E. [2 ]
机构
[1] Univ Hosp Alexandroupolis, Outpatient Clin Rheumatol, Alexandroupolis, Greece
[2] Democritus Univ Thrace, Dept Internal Med 2, Unit Special Infect Dis, Alexandroupolis, Greece
来源
ARCHIVES OF HELLENIC MEDICINE | 2010年 / 27卷 / 03期
关键词
Antiretroviral therapy; Antirheumatic drugs; Autoantibodies; HIV-infection; Rheumatic manifestations;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Various rheumatic manifestations may develop in HIV-infected patients. In the musculoskeletal system the main conditions which have been reported are reactive, psoriatic or rheumatoid-like arthritis, gout, infective arthritis, osteomyelitis, osteomalacia, osteonecrosis, myositis, pyomyositis and rhabdomyolysis. In addition, manifestations resembling connective tissue diseases may be seen, particularly systemic lupus erythematosus (SLE), Sjogren's syndrome and a whole spectrum of conditions characterized by vasculitis (polyarteritis nodosa, primary vasculitis of the central nervous system, Henoch-Schonlein purpura, Wegener's granulomatosis etc.). Latterly, a correlation has been found between TNF alpha levels and parameters of the progression of HIV-infection, and many studies have shown that anti-TNF alpha drugs are relatively safe and can provide improvement of specific rheumatic disorders in HIV-infected patients. As HIV-infection has become a pandemic, knowledge of these manifestations in everyday clinical practice is of great importance, because of problems in differential diagnosis between this infection and other autoimmune diseases. The production of autoantibodies in rheumatic diseases can affect the detection of anti-HIV antibodies, leading to false positive results in ELISA. Conversely, HIV-infection and antiretroviral therapy can modify the course of many rheumatic diseases, while the risk of side effects due to antirheumatic drugs may be increased in HIV (+) patients.
引用
收藏
页码:460 / 470
页数:11
相关论文
共 97 条
[1]   Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis [J].
Aboulafia, DM ;
Bundow, D ;
Wilske, K ;
Ochs, UI .
MAYO CLINIC PROCEEDINGS, 2000, 75 (10) :1093-1098
[2]   BMD is reduced in HIV-infected men irrespective of treatment [J].
Amiel, C ;
Ostertag, A ;
Slama, L ;
Baudoin, C ;
N'Guyen, T ;
Lajeunie, E ;
Neit-Ngeilh, L ;
Rozenbaum, W ;
De Vernejoul, MC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) :402-409
[3]  
Ascherl G, 1999, BLOOD, V93, P4232
[4]   TRANSIENT MYASTHENIA-GRAVIS DURING HIV-INFECTION [J].
AUTHIER, FJ ;
DEGRISSAC, N ;
DEGOS, JD ;
GHERARDI, RK .
MUSCLE & NERVE, 1995, 18 (08) :914-916
[5]   Changing spectrum of the diffuse infiltrative lymphocytosis syndrome [J].
Basu, Dhiman ;
Williams, Francis M. ;
Ahn, Chul W. ;
Reveille, John D. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (03) :466-472
[6]  
Belzunegui J, 2004, CLIN EXP RHEUMATOL, V22, P343
[7]   RHEUMATIC MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
BERMAN, A ;
ESPINOZA, LR ;
DIAZ, JD ;
AGUILAR, JL ;
ROLANDO, T ;
VASEY, FB ;
GERMAIN, BF ;
LOCKEY, RF .
AMERICAN JOURNAL OF MEDICINE, 1988, 85 (01) :59-64
[8]   Acute monoarthritis complicating therapy with indinavir [J].
Brooks, JI ;
Gallicano, K ;
Garber, G ;
Angel, JB .
AIDS, 2000, 14 (13) :2064-2065
[9]   Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia [J].
Brown, TT ;
Ruppe, MD ;
Kassner, R ;
Kumar, P ;
Kehoe, T ;
Dobs, AS ;
Timpone, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1200-1206
[10]   Osteoarticular infections in HIV-infected patients - 23 cases among 1,515 HIV-infected patients [J].
Busch, Vincent J. J. F. ;
Regez, Rosa M. ;
Heere, Bastiaan ;
Willems, W. Jaap .
ACTA ORTHOPAEDICA, 2007, 78 (06) :786-790